Profound Medical

$18.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.28 (+1.51%) Today
$0.00 (0.00%) As of 4:01 PM EST after-hours

Why Robinhood?

You can buy or sell PROF and other stocks, options, and ETFs commission-free!

About PROF

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA. The listed name for PROF is Profound Medical Corp. Common Stock.

CEO
Arun S. Menawat
Employees
75
Headquarters
Mississauga, Ontario
Founded
2008
Market Cap
369.75M
Price-Earnings Ratio
Dividend Yield
Average Volume
128.24K
High Today
$19.01
Low Today
$18.51
Open Price
$18.67
Volume
43.41K
52 Week High
$21.29
52 Week Low
$6.53

Collections

PROF Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 2, After Hours

You May Also Like